RTI and Aziyo Partner on ViBone Cellular Matrix

Aziyo Biologics will provide ViBone® cellular bone matrix to RTI Surgical for exclusive distribution in the U.S. Further, the companies will partner on new research for the product.

ViBone is a next-gen viable bone matrix designed to perform like high-quality autograft. ViBone is processed using a proprietary method designed to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us